Constellation Brands Reports Q2 FY2027 Results, Announces SpikedAde Acquisition, and Declares Dividend

Constellation Brands, Inc. (NYSE: STZ) Form 8-K Summary

1. Q2 Fiscal 2027 Financial Highlights

• Net Sales: $2,633 million, representing an increase of 6% year-over-year.
• Operating Income:
  • Reported operating income was $805 million (-8% YoY).
  • Comparable operating income was $897 million (+1% YoY).
• Earnings Per Share (EPS):
  • Reported EPS of $3.32 (+25% YoY).
  • Comparable EPS of $3.74 (+3% YoY).
• Cash Flow: Generated $1.5 billion in year-to-date operating cash flow (-1% YoY) and $1.1 billion in free cash flow (+4% YoY).

2. Segment Performance

• Beer Business:
  • Net sales rose 5% to $2,473.6 million, supported by a 5.5% increase in shipment volume.
  • Operating income increased 1% to $964.2 million, with operating margin at 39.0% (-160 bps).
  • Depletions decreased 0.6%, with declines in Modelo Especial (~2%) and Corona Extra (~5%) partially offset by double-digit gains in Pacifico (+19%) and Victoria (+15%).
• Wine and Spirits Business:
  • Net sales climbed 17% to $159.4 million, with shipments up 15.4%.
  • Operating income rebounded to $6.1 million compared to a $(19.8) million loss in Q2 FY2026.
  • Depletions grew 10.2%, led by Kim Crawford (+11%) and Mi CAMPO (+51%).

3. Strategic M&A: SpikedAde Acquisition

• Constellation completed the acquisition of SpikedAde, an emerging spirit-based ready-to-drink (RTD) beverage brand.
• Terms: $75 million cash payment at closing for 100% ownership, alongside up to $278 million in contingent consideration over five years tied to future operational and financial milestones.
• The transaction does not alter existing fiscal 2027 financial guidance.

4. Capital Allocation & Fiscal 2027 Outlook

• Dividends: Declared a quarterly cash dividend of $1.03 per Class A Common share and $0.93 per Class 1 Convertible Common share, payable November 13, 2026, to holders of record as of October 30, 2026.
• Share Repurchases: Repurchased $530 million in common stock year-to-date through September 2026.
• FY2027 Guidance:
  • Updated reported EPS to $11.85–$12.55.
  • Reaffirmed comparable EPS to $11.20–$11.90.
  • Target operating cash flow of $2.4–$2.5 billion, capital expenditures of ~$800 million, and free cash flow of $1.6–$1.7 billion.